CS logo
small CS logo
Jefferson Hospital for Neuroscience

Philadelphia, Pennsylvania, United States
Hospital in Philadelphia, Pennsylvania
900 Walnut St, Philadelphia, PA 19107

About Jefferson Hospital for Neuroscience


Jefferson Hospital for Neuroscience is a hospital in Center City, Philadelphia, affiliated with Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia. The Hospital focuses on treating brain-related diseases and disorders. It is the only hospital of its kind in the Philadelphia area.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Jefferson Hospital for Neuroscience


During the past decade, Jefferson Hospital for Neuroscience conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Jefferson Hospital for Neuroscience" #1 collaborator was "Pfizer" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Jefferson Hospital for Neuroscience


According to Clinical.Site data, the most researched conditions in "Jefferson Hospital for Neuroscience" are "Alzheimer's Disease" (3 trials), "Alzheimer Disease" (1 trials), "Brain Cancer" (1 trials), "Brain Tumor" (1 trials) and "GBM" (1 trials). Many other conditions were trialed in "Jefferson Hospital for Neuroscience" in a lesser frequency.

Clinical Trials Intervention Types at Jefferson Hospital for Neuroscience


Most popular intervention types in "Jefferson Hospital for Neuroscience" are "Drug" (6 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials), "Bapineuzumab" (1 trials) and "Dendritic cell immunotherapy" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Jefferson Hospital for Neuroscience


The vast majority of trials in "Jefferson Hospital for Neuroscience" are 7 trials for "All" genders.

Clinical Trials Status at Jefferson Hospital for Neuroscience


Currently, there are NaN active trials in "Jefferson Hospital for Neuroscience". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jefferson Hospital for Neuroscience, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Jefferson Hospital for Neuroscience, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".